Advita Ortho CEO Aurelio Sahagun outlines how the company’s award-winning Newton® Knee Balancing Technology is redefining ...

ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...

New research explores how artificial intelligence foundation models trained on electronic health record data can be tested to ...

(NASDAQ: NXXT ), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today ...

Addressing the microbiome's translational gap involves understanding biological complexity and developing function-driven, patient-specific interventions.

WholeSum raised new funding to expand its AI-based qualitative analytics platform, helping organisations extract reliable ...

The GC–MS dataset was integrated with the sensory data using a series of exploratory and predictive multivariate statistical ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Democratized access to validated, reproducible, multistep & multiscale chemistry for modern molecular discovery ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United ...

Wearable data collection devices, combined with artificial intelligence, may help clinicians detect complications earlier and improve patient care.

Routine reactor emissions pose no meaningful health risk to the US workers and population, a health physicist and a nuclear ...